Skilled nursing facilities, assisted living communities, and other long term care settings carry a combination of risk factors that few other workplaces share. Staff have routine, often unsupervised access to controlled substances. Residents are frequently unable to advocate for themselves or report concerns. Shifts run around the clock, including overnight hours when supervision is thinnest. For administrators, directors of nursing, and HR teams, a well built drug testing program is one of the more practical tools for protecting residents and staying ahead of regulatory scrutiny.
This guide walks through why long term care is considered a higher risk environment, what the regulatory landscape actually requires, how to structure a testing program across the employment lifecycle, which panels make sense in a healthcare setting, and how testing connects to state nurse aide registries and licensing boards when diversion is confirmed.
Why long term care is a higher risk setting
Several factors combine to make nursing homes and assisted living communities a setting where medication diversion and impaired caregiving are genuine operational risks rather than abstract concerns.
Controlled substance access and diversion
Residents in skilled nursing and long term care commonly receive opioids for pain, benzodiazepines for anxiety or agitation, and other scheduled medications as part of routine care. Staff who pass medications, manage the medication cart, or work in the pharmacy have direct access to these drugs, and the volume moving through a facility on any given day can make small discrepancies easy to overlook. The Drug Enforcement Administration's Diversion Control Division tracks how controlled substances move out of legitimate handling channels in healthcare settings, and long term care is consistently identified as an environment where diversion by employees, not outside actors, is the primary threat.
Vulnerable residents
Many residents live with dementia, cognitive decline, or physical limitations that make it difficult or impossible for them to report a caregiver who is impaired, who is skimming their medication, or who is otherwise providing substandard care. That silence removes a layer of accountability that exists in most other industries, where a customer or coworker might flag a problem directly.
Around the clock staffing
Care does not stop at 5 p.m. Overnight and weekend shifts often run with fewer supervisors on site, less clinical oversight, and lower staffing ratios. An employee who is impaired or actively diverting medication has more room to operate unnoticed during these windows than during a fully staffed day shift.
No single federal mandate, but plenty of pressure to act
Unlike safety sensitive transportation roles, there is no single federal law that requires every nursing home to drug test every employee. What exists instead is a layered set of obligations that push facilities toward robust screening even without a blanket testing mandate.
The Centers for Medicare and Medicaid Services sets requirements of participation for facilities that accept Medicare and Medicaid residents, including expectations around resident protection from abuse, neglect, and misappropriation of property. Facilities are required to investigate allegations promptly and to report confirmed findings, and staff found to have committed abuse, neglect, or misappropriation involving controlled substances can be entered into a state nurse aide registry, which effectively bars them from working in certified nursing roles elsewhere. The full survey guidance for long term care facilities is laid out in CMS's State Operations Manual Appendix PP for long term care facilities, and the registry mechanism itself is codified in the federal requirement for a nurse aide registry under 42 CFR 483.156.
On top of federal survey requirements, many states have their own caregiver laws that address background checks, abuse registries, and in some cases drug testing specifically for licensed nursing home staff. These state rules vary considerably, including whether random testing is permitted at all, so facility policy needs to be checked against the law in the state where the facility operates before a random testing component is added. General background on how federal workplace testing programs are structured, including specimen types and panel composition, is available through the Substance Abuse and Mental Health Services Administration's workplace program and the Mandatory Guidelines for Federal Workplace Drug Testing Programs published in the Federal Register.
Building the program: when to test
A defensible program layers several types of testing across the employment relationship rather than relying on a single checkpoint.
Pre-employment testing
Screening before a candidate starts, especially for roles with direct resident contact or medication access, sets the baseline and signals that the facility takes the issue seriously from day one.
Reasonable suspicion testing
When a supervisor observes signs consistent with impairment, slurred speech, unsteady gait, unexplained absences from the floor, or erratic documentation, a same shift test can be ordered. This requires supervisors trained to recognize and document specific, observable behavior rather than acting on rumor.
Post-incident testing
A medication error, a resident fall during a medication pass, or any incident where staff impairment could plausibly be a contributing factor is a reasonable trigger for testing as part of the incident investigation.
Random testing where state law allows
Some states permit random testing for healthcare employees, particularly those with access to controlled substances. Where it is legally available, random testing is one of the few tools that catches diversion or use that would otherwise go undetected because no single incident triggered suspicion.
Diversion-triggered testing
Medication count discrepancies, unusual waste logs, irregular activity on an automated dispensing cabinet, or a pattern of a specific employee being present for repeated shortages are all reasons to test a specific individual as part of a diversion investigation, separate from the routine categories above.
| Trigger | Recommended panel or action |
|---|---|
| Pre-employment, any role with resident or medication access | Expanded panel including opioids, fentanyl, and benzodiazepines, with lab confirmation before the start date |
| Reasonable suspicion (observed impairment) | On site point of care collection the same shift, non-negative results sent to a lab for confirmation, MRO review before any action |
| Post-incident (medication error, resident injury) | Post-incident panel tied to the incident report, chain of custody documentation attached to the personnel file |
| Random, where state law and facility policy allow | Expanded panel focused on staff with controlled substance access, run on a documented rotation |
| Diversion investigation (count discrepancy, waste log irregularity) | Targeted expanded panel for the implicated employee, findings shared with the director of nursing and compliance officer, pharmacy records preserved |
Choosing the right panel for a healthcare setting
A standard five panel test, built around older street drug categories, is a poor fit for long term care because it misses many of the medications actually present in the building. A caregiver diverting a resident's oxycodone, tramadol, or a benzodiazepine can pass a basic five panel test without difficulty, since none of those substances are reliably captured by it.
For a healthcare setting, an expanded panel should include the opioids most commonly prescribed to residents, including oxycodone and fentanyl, along with benzodiazepines and tramadol. This is the same logic that applies in acute care, where diversion risk and medication access drive panel selection rather than a generic default; our related guide on hospital employee drug testing covers the same expanded panel reasoning in more detail for acute care staff. Facilities that stock their own multi panel drug test cups for on site screening should confirm the specific panel configuration covers fentanyl, oxycodone, benzodiazepines, and tramadol rather than assuming a generic multi panel product already includes them.
Point of care cups versus lab confirmation and MRO review
Point of care cups are useful for immediate, on site screening, particularly for reasonable suspicion situations where a facility needs a result before the end of a shift. But a point of care result is a screening result, not a final determination. Any non-negative point of care result should be sent to a certified laboratory for confirmation using gas chromatography or liquid chromatography mass spectrometry, which resolves false positives from cross reactivity and confirms the specific substance and concentration.
Confirmed results should then go through review by a Medical Review Officer before the facility takes any employment action. An MRO is a licensed physician trained to interview the employee, review prescriptions, and determine whether a positive result has a legitimate medical explanation. This step protects both the resident population and the employee, and it is the same process used across other regulated and healthcare employment settings, as described in our guide to the medical review officer drug test process. Skipping MRO review and acting on a screening result alone is one of the more common ways facilities expose themselves to wrongful termination claims.
Coordinating with state nurse aide registries and licensing boards
When an investigation confirms diversion, resident abuse, neglect, or misappropriation of resident property involving a certified nursing assistant, federal rules require the finding to be reported to the state's nurse aide registry, which then bars that individual from certified nursing assistant work in other facilities. Licensed staff, including LPNs and RNs, are typically reportable to the state board of nursing rather than the nurse aide registry, and many boards have separate impaired practitioner or diversion monitoring programs that a facility may need to notify depending on state law.
This is where documentation quality matters most. A registry or board referral built on a clean chain of custody, a lab confirmed result, and a documented MRO determination is far more defensible than one built on a point of care screen alone. Facilities should have a clear internal process for who initiates a registry or board report, what documentation accompanies it, and how quickly it happens once an investigation concludes.
Documentation and chain of custody
Every test in the program, regardless of the trigger, should be accompanied by a proper chain of custody form that records who collected the specimen, when, how it was sealed, and who handled it at each step until it reached the lab. This documentation is what makes a positive result stand up to challenge, whether that challenge comes from an employee grievance, a licensing board hearing, or a wrongful termination claim. Facilities should also retain incident reports, reasonable suspicion observation forms completed by the supervisor at the time of the event, and the MRO's final determination letter in the employee's file, separate from general personnel records where required by state law.
Frequently asked questions
Is nursing home employee drug testing required by federal law?
There is no single federal law requiring every nursing home to drug test every employee. Federal requirements focus on resident protection, investigation of abuse and neglect allegations, and reporting confirmed findings to a state nurse aide registry. State caregiver laws and individual facility policy are what typically drive the actual testing program.
What drug panel should a long term care facility use?
An expanded panel that includes fentanyl, oxycodone, benzodiazepines, and tramadol is a better fit than a standard five panel test, because these are the medications most commonly present and most commonly diverted in a long term care setting.
Can a facility drug test on a random basis?
It depends on the state. Some states permit random testing for healthcare employees with controlled substance access, while others restrict it. Facility policy should be checked against state law before implementing a random testing component.
What happens if a caregiver tests positive after a diversion investigation?
A confirmed lab result should go through Medical Review Officer review before any action is taken. If diversion, abuse, or neglect is confirmed, federal rules generally require reporting certified nursing assistants to the state nurse aide registry, and licensed staff are typically reportable to the state board of nursing.
Do point of care cups need lab confirmation?
Yes. A point of care cup provides a screening result. Any non-negative screening result should be sent to a certified laboratory for confirmation before it is treated as a positive result or used as the basis for employment action.
Who reviews a positive drug test result before a facility acts on it?
A Medical Review Officer, a licensed physician trained in reviewing drug test results, interviews the employee and reviews any prescriptions before a confirmed positive result is finalized and reported to the facility.
This article is general information for long term care administrators and HR teams, not legal advice. Facilities should confirm requirements with their own counsel and their state's health department before finalizing a drug testing policy.
